153 related articles for article (PubMed ID: 8596863)
1. Alzheimer disease and subcortical ischemic vascular dementia: evaluation by combining MR imaging segmentation and H-1 MR spectroscopic imaging.
MacKay S; Ezekiel F; Di Sclafani V; Meyerhoff DJ; Gerson J; Norman D; Fein G; Weiner MW
Radiology; 1996 Feb; 198(2):537-45. PubMed ID: 8596863
[TBL] [Abstract][Full Text] [Related]
2. Regional gray and white matter metabolite differences in subjects with AD, with subcortical ischemic vascular dementia, and elderly controls with 1H magnetic resonance spectroscopic imaging.
MacKay S; Meyerhoff DJ; Constans JM; Norman D; Fein G; Weiner MW
Arch Neurol; 1996 Feb; 53(2):167-74. PubMed ID: 8639067
[TBL] [Abstract][Full Text] [Related]
3. Different patterns of N-acetylaspartate loss in subcortical ischemic vascular dementia and AD.
Schuff N; Capizzano AA; Du AT; Amend DL; O'Neill J; Norman D; Jagust WJ; Chui HC; Kramer JH; Reed BR; Miller BL; Yaffe K; Weiner MW
Neurology; 2003 Aug; 61(3):358-64. PubMed ID: 12913198
[TBL] [Abstract][Full Text] [Related]
4. H-1 MR spectroscopic imaging of white matter signal hyperintensities: Alzheimer disease and ischemic vascular dementia.
Constans JM; Meyerhoff DJ; Gerson J; MacKay S; Norman D; Fein G; Weiner MW
Radiology; 1995 Nov; 197(2):517-23. PubMed ID: 7480705
[TBL] [Abstract][Full Text] [Related]
5. Alzheimer disease: quantitative H-1 MR spectroscopic imaging of frontoparietal brain.
Schuff N; Amend DL; Meyerhoff DJ; Tanabe JL; Norman D; Fein G; Weiner MW
Radiology; 1998 Apr; 207(1):91-102. PubMed ID: 9530304
[TBL] [Abstract][Full Text] [Related]
6. Cognitive impairment: assessment with brain magnetic resonance imaging and proton magnetic resonance spectroscopy.
Weiss U; Bacher R; Vonbank H; Kemmler G; Lingg A; Marksteiner J
J Clin Psychiatry; 2003 Mar; 64(3):235-42. PubMed ID: 12716263
[TBL] [Abstract][Full Text] [Related]
7. Effects of subcortical ischemic vascular dementia and AD on entorhinal cortex and hippocampus.
Du AT; Schuff N; Laakso MP; Zhu XP; Jagust WJ; Yaffe K; Kramer JH; Miller BL; Reed BR; Norman D; Chui HC; Weiner MW
Neurology; 2002 Jun; 58(11):1635-41. PubMed ID: 12058091
[TBL] [Abstract][Full Text] [Related]
8. Proton magnetic resonance spectroscopy of vascular- and Alzheimer-type dementia.
Kattapong VJ; Brooks WM; Wesley MH; Kodituwakku PW; Rosenberg GA
Arch Neurol; 1996 Jul; 53(7):678-80. PubMed ID: 8929176
[TBL] [Abstract][Full Text] [Related]
9. Absolute quantification in proton magnetic resonance spectroscopy is superior to relative ratio to discriminate Alzheimer's disease from Binswanger's disease.
Watanabe T; Shiino A; Akiguchi I
Dement Geriatr Cogn Disord; 2008; 26(1):89-100. PubMed ID: 18617735
[TBL] [Abstract][Full Text] [Related]
10. The value of diffusion tensor imaging in the differential diagnosis of subcortical ischemic vascular dementia and Alzheimer's disease in patients with only mild white matter alterations on T2-weighted images.
Fu JL; Zhang T; Chang C; Zhang YZ; Li WB
Acta Radiol; 2012 Apr; 53(3):312-7. PubMed ID: 22416261
[TBL] [Abstract][Full Text] [Related]
11. Axonal injury and membrane alterations in Alzheimer's disease suggested by in vivo proton magnetic resonance spectroscopic imaging.
Meyerhoff DJ; MacKay S; Constans JM; Norman D; Van Dyke C; Fein G; Weiner MW
Ann Neurol; 1994 Jul; 36(1):40-7. PubMed ID: 8024260
[TBL] [Abstract][Full Text] [Related]
12. The profile of hippocampal metabolites differs between Alzheimer's disease and subcortical ischemic vascular dementia, as measured by proton magnetic resonance spectroscopy.
Shiino A; Watanabe T; Shirakashi Y; Kotani E; Yoshimura M; Morikawa S; Inubushi T; Akiguchi I
J Cereb Blood Flow Metab; 2012 May; 32(5):805-15. PubMed ID: 22314267
[TBL] [Abstract][Full Text] [Related]
13. [Dementias: diagnostic contribution of imaging and proton magnetic resonance spectroscopy].
Arana E; MartÃnez-Granados B; Marti-Bonmati L; MartÃnez-Bisbal MC; Gil A; Blasco C; Celda B
Neurologia; 2007 Jun; 22(5):267-74. PubMed ID: 17508300
[TBL] [Abstract][Full Text] [Related]
14. Discriminative analysis of early-stage Alzheimer's disease and normal aging with automatic segmentation technique in subcortical gray matter structures: a multicenter in vivo MRI volumetric and DTI study.
Li YD; He HJ; Dong HB; Feng XY; Xie GM; Zhang LJ
Acta Radiol; 2013 Dec; 54(10):1191-200. PubMed ID: 23878359
[TBL] [Abstract][Full Text] [Related]
15. 1H-MRS evaluation of metabolism in Alzheimer's disease and vascular dementia.
Jones RS; Waldman AD
Neurol Res; 2004 Jul; 26(5):488-95. PubMed ID: 15265265
[TBL] [Abstract][Full Text] [Related]
16. MR spectroscopy of Alzheimer disease.
Rhinehart DL; Cox LA; Long BW
Radiol Technol; 1998; 70(1):23-8. PubMed ID: 9779506
[TBL] [Abstract][Full Text] [Related]
17. Probable Alzheimer disease: diagnosis with proton MR spectroscopy.
Shonk TK; Moats RA; Gifford P; Michaelis T; Mandigo JC; Izumi J; Ross BD
Radiology; 1995 Apr; 195(1):65-72. PubMed ID: 7892497
[TBL] [Abstract][Full Text] [Related]
18. Regional metabolic changes in the hippocampus and posterior cingulate area detected with 3-Tesla magnetic resonance spectroscopy in patients with mild cognitive impairment and Alzheimer disease.
Wang Z; Zhao C; Yu L; Zhou W; Li K
Acta Radiol; 2009 Apr; 50(3):312-9. PubMed ID: 19235582
[TBL] [Abstract][Full Text] [Related]
19. Increased differentiation of intracranial white matter lesions by multispectral 3D-tissue segmentation: preliminary results.
Mohamed FB; Vinitski S; Gonzalez CF; Faro SH; Lublin FA; Knobler R; Gutierrez JE
Magn Reson Imaging; 2001 Feb; 19(2):207-18. PubMed ID: 11358659
[TBL] [Abstract][Full Text] [Related]
20. [Patchy changes in white matter in cranial computerized and magnetic resonance tomography--significance for (differential) diagnosis of dementia of the Alzheimer type and vascular dementia].
Stoppe G; Staedt J; Bruhn H
Fortschr Neurol Psychiatr; 1995 Nov; 63(11):425-40. PubMed ID: 8575717
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
